🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Previous work demonstrates that the red blood cells of older adults do not ...
Status
Completed
Location
Colorado State University, Dept. of Health and Exercise Science
Start Date
2017-07-14
Trial ID
NCT03404843
Treatments Being Tested
This study will examine whether fasudil is effective and safe in treating p...
Status
Unknown
Location
Peking University Third Hospital
Start Date
2013-09
Trial ID
NCT01935518
Treatments Being Tested
A Phase 2a Open-Label Preliminary Safety, Efficacy, and Biomarker Study of ...
Status
Active Not Recruiting
Location
Neuromuscular Research Center
Start Date
2021-12-22
Trial ID
NCT05218668
Treatments Being Tested
Fasudil, a Rho kinase inhibitor, is believed to reduce wandering behaviors ...
Status
Completed
Location
New England Institute for Clinical Research
Start Date
2020-12-15
Trial ID
NCT04793659
Treatments Being Tested
The study aims to evaluate whether an early intracoronary administration of...
Status
Unknown
Location
Multiple Locations
Start Date
2019-07-01
Trial ID
NCT03753269
Treatments Being Tested
To evaluate the causal relationship between Rho/Rho kinase overactivity and...
Status
Terminated
Location
Brigham and Women's Hospital
Start Date
2008-03-13
Trial ID
NCT00670202
Treatments Being Tested
The purpose of the study is to evaluate how the rho kinase inhibitor, fasud...
Status
Completed
Location
Brigham and Women's Hospital
Start Date
2002-06
Trial ID
NCT00120718
Treatments Being Tested
The high incidence of prostate cancer is one of the important diseases that...
Status
Recruiting
Location
Zhongda Hospital
Start Date
2025-02-16
Trial ID
NCT06861192
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative diso...
Status
Completed
Location
Centre Hospitalier Universitaire Marseille
Start Date
2019-02-20
Trial ID
NCT03792490
Eligible eyes are randomized to two groups. Group A will receive three intr...
Status
Completed
Location
Multiple Locations
Start Date
2013-01
Trial ID
NCT01823081